title: HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland.
abstract: Recently, we found that mutation of the C-terminus of transcription factor hexamethylene bisacetamide-inducible protein 1 (HEXIM1) in mice leads to abnormalities in cardiovascular development because of aberrant vascular endothelial growth factor (VEGF) expression. HEXIM1 regulation of some genes has also been shown to be positive transcription elongation factor b (P-TEFb) dependent. However, it is not known whether HEXIM1 regulates VEGF in the mammary gland. We demonstrate that HEXIM1 regulates estrogen-induced VEGF transcription through inhibition of estrogen receptor-alpha recruitment to the VEGF promoter in a P-TEFb-independent manner in MCF-7 cells. Under hypoxic conditions, HEXIM1 inhibits estrogen-induced hypoxia-inducible factor-1 alpha (HIF-1alpha) protein expression and recruitment of HIF-1alpha to the hypoxia-response element in the VEGF promoter. In the mouse mammary gland, increased HEXIM1 expression decreased estrogen-driven VEGF and HIF-1alpha expression. Conversely, a mutation in the C-terminus of HEXIM1 (HEXIM1(1-312)) led to increased VEGF and HIF-1alpha expression and vascularization in mammary glands of heterozygous HEXIM1(1-312) mice when compared with their wild-type littermates. In addition, HEXIM1(1-312) mice have a higher incidence of carcinogen-induced mammary tumors with increased vascularization, suggesting an inhibitory role for HEXIM1 during angiogenesis. Taken together, our data provide evidence to suggest a novel role for HEXIM1 in cancer progression.
authors.affiliation: Department of Pharmacology, Rainbow Babies and Children's Hospital, Cleveland, OH, USA.
authors.forename: N
authors.initials: N
authors.lastname: Ogba
authors.forename: Y Q
authors.initials: YQ
authors.lastname: Doughman
authors.forename: L J
authors.initials: LJ
authors.lastname: Chaplin
authors.forename: Y
authors.initials: Y
authors.lastname: Hu
authors.forename: M
authors.initials: M
authors.lastname: Gargesha
authors.forename: M
authors.initials: M
authors.lastname: Watanabe
authors.forename: M M
authors.initials: MM
authors.lastname: Montano
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000633:toxicity; D015687:Cell Hypoxia / Q000187:drug effects; D045744:Cell Line, Tumor; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D004958:Estradiol / Q000494:pharmacology; D047628:Estrogen Receptor alpha / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D009154:Mutation; D009389:Neovascularization, Pathologic / Q000378:metabolism; D018919:Neovascularization, Physiologic; D042925:Positive Transcriptional Elongation Factor B / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000235:genetics; D016601:RNA-Binding Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D020218:Response Elements; D014157:Transcription Factors; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics* / Q000378:metabolism*
chemical_list: D002273:Carcinogens; D047628:Estrogen Receptor alpha; C476123:HEXIM1 protein, human; C497443:Hif1a protein, mouse; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D016601:RNA-Binding Proteins; D014157:Transcription Factors; D042461:Vascular Endothelial Growth Factor A; D004958:Estradiol; D042925:Positive Transcriptional Elongation Factor B
references.citation: Biol Reprod. 2009 Aug;81(2):378-87
references.pmid: 19420388
references.citation: Cancer Res. 2003 Aug 15;63(16):5151-8
references.pmid: 12941847
references.citation: Breast Cancer Res. 2004;6(4):R450-9
references.pmid: 15217513
references.citation: J Steroid Biochem Mol Biol. 2007 May;104(3-5):169-79
references.pmid: 17475478
references.citation: Mol Endocrinol. 2005 Aug;19(8):2006-19
references.pmid: 15774498
references.citation: J Clin Invest. 2006 Mar;116(3):561-70
references.pmid: 16511588
references.citation: FASEB J. 2007 Dec;21(14):3994-4004
references.pmid: 17625068
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8555-60
references.pmid: 15941832
references.citation: Cancer Res. 2002 Apr 1;62(7):1948-51
references.pmid: 11929808
references.citation: Genes Dev. 2004 Oct 15;18(20):2437-68
references.pmid: 15489290
references.citation: Nat Med. 2003 Jun;9(6):669-76
references.pmid: 12778165
references.citation: Endocrinology. 2009 Dec;150(12):5405-14
references.pmid: 19819950
references.citation: Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2514-23
references.pmid: 17872453
references.citation: Endocr Relat Cancer. 2006 Sep;13(3):667-87
references.pmid: 16954424
references.citation: Breast Cancer Res Treat. 2001 May;67(1):51-60
references.pmid: 11518466
references.citation: Nat Rev Cancer. 2008 Aug;8(8):579-91
references.pmid: 18596824
references.citation: Circ Res. 2008 Feb 29;102(4):415-22
references.pmid: 18079413
references.citation: Oncogene. 2005 Aug 25;24(36):5576-88
references.pmid: 15940264
references.citation: Endocr Relat Cancer. 2006 Sep;13(3):739-49
references.pmid: 16954428
references.citation: Mol Carcinog. 1995 Oct;14(2):75-83
references.pmid: 7576102
references.citation: J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):311-7
references.pmid: 11162939
references.citation: Endocrinology. 2006 Jul;147(7):3285-95
references.pmid: 16574784
references.citation: Cancer Res. 2008 Sep 1;68(17):7015-24
references.pmid: 18757415
references.citation: Cancer Res. 1999 Sep 1;59(17):4276-84
references.pmid: 10485472
references.citation: Endocrinology. 2007 May;148(5):2363-74
references.pmid: 17272396
references.citation: Mol Endocrinol. 2005 May;19(5):1191-9
references.pmid: 15695373
references.citation: Cancer Res. 2002 Sep 1;62(17):4977-84
references.pmid: 12208749
references.citation: Microbiol Mol Biol Rev. 2006 Sep;70(3):646-59
references.pmid: 16959964
references.citation: Oncogene. 2004 Feb 5;23(5):1052-63
references.pmid: 14647449
references.citation: Oncologist. 2004;9 Suppl 1:43-9
references.pmid: 15178815
references.citation: Oncogene. 2002 Oct 31;21(50):7730-9
references.pmid: 12400015
references.citation: Cancer Res. 2007 Jan 15;67(2):563-72
references.pmid: 17234764
references.citation: Br J Cancer. 2005 Oct 31;93(9):1005-10
references.pmid: 16234819